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ABSTRACT

Type 2 Diabetes and the Risk of Osteoporotic Hip Fracture in Utah Men and Women

by

Megan Bunch, Master of Science
Utah State University, 2006

Major Professor: Dr. Ronald G. Munger
Department: Nutrition and Food Sciences

Prior studies have unequivocally established a consistent association between
osteoporotic hip fracture risk and type 2 diabetes mellitus. One reason this
association still remains unclear is primarily due to the limited amount of research
conducted in this area. The Utah Study of Nutrition and Bone Health (USNBH) is a
case-control study conducted in Utah during the period of 1997-2001 to determine
risk factors for osteoporotic hip fracture. All study participants (n = 2590) were
determined from Utal1 residents 50-90 years of age. Cases were determined from 18
Utah hospitals during 1997-2001. Age and gender-matched controls were randomly
selected from the Utah Drivers License pool if less than 65 years of age and the
Medicare databases if greater than 65 years of age. Logistic regression models were
used to determine the association between type 2 diabetes and hip fracture risk.
Logistic regression modeling controlled for gender, body mass index , smoking status,
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alcohol use, physical activity , education level, and estrogen use in women. The risk
of hip fracture was associated with type 2 diabetes. The significant correlation was
primarily found in females in which the risk of hip fracture increased accompanying
diagnosis of type 2 diabetes. Estrogen usage in females decreased (p < 0.0001) hip
fracture risk in both former or current users. Physical activity significantly decreased
the risk of hip fracture for females (p < 0.0001) and for males (p = 0.001). Smoking
and alcohol use may increase the risk of hip fracture, especially in women. This
study substantiates the hypothesis that type 2 diabetes mellitus increases the risk of
hip fracture.
(62 pages)
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INTRODUCTION

The Utah Study of Nutrition and Bone Health (USNBH) was a case-control
study conducted in Utah during the period of 1997-2001 to determine risk factors for
osteoporotic hip fractures. All study participants were determined from Utah
residents aged 50-90 years. The intent of this segment of the USNBH sh1dy was to
verify putative factors associated with complications of type 2 diabetes mellitus and
osteoporotic hip :fracture.
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REVIEW OF LITERATURE

Osteoporosis
Osteoporosis is a systemic skeletal disorder characterized by low bone mass
and deterioration of bone leading to bone fragility and susceptibility to fractures (1 ).
The 1990 Consensus Development Panel defined osteoporosis as a "disease
characterized by low bone mass and microarchitectural deterioration of bone tissue,
leading to enhanced bone fragility and increase in fracture risk." (2).
Bone loss is a natural process of aging occurring in both genders following
peak bone mass attainment. Peak bone mass is attained by approximately 25 years of
age (3). Bone loss can be attributed to failure to achieve optimal peak bone mass and
impaired bone formation during bone modeling processes (4). Hunter et al. (5)
reported that many studies have determined marked bone loss in persons 30 to 40
years of age. Bone loss in males is approximately two-thirds that of women (5).
Beginning in the middle of the third decade, women lose approximately 35%
of their cortical bone and 50% of their trabecular bone (5). During the first year of
menopause, an immediate reduction in bone mass occurs due to an accelerated rate of
bone loss. The increased rate lasts nearly 10 years after menopause followed by
continuous age-related bone loss (5). An average reduction in bone mineral density
(BMD) ai:nong postmenopausaL.wornen-not-recei-¥-rnghormonexeplacement therapy
for a period of 10 years has been associated with a doubling in fracture risk (2).
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There is not a good explanation for bone deterioration (2). Bone tissue
continuously undergoes remodeling to replace old bone tissue with new bone ti·ssue.
Bone remodeling involves mesenchymal osteoblastic activities for bone formation
and hematopoietic osteoclastic activities for bone resorption (4,6). Homeostatic
imbalance in the remodeling process leads to increased bone resorption and decreased
bone formation. In addition, bone resorption may create weakened trabecular
structures resulting in deterioration of bone tissue (2,3,6).
Osteoporosis is typically asymptomatic until a fracture occurs, although one in
five women will not be diagnosed with osteoporosis even after a fracture occurs (7).
As a result of the asymptomatic nature of osteoporosis, it is likely that the actual
prevalence of osteoporosis is lmderestimated (7). Clinical diagnosis of osteoporosis
is generally confirmed by low BMD . However, diagnosis of osteoporosis is also
confirmed on the basis of personal history of osteoporotic fractures at any given time
(2). The World Health Organi zation has defined low BMD as greater than 2.5
standard deviations below the mean BMD values for healthy adults 30-40 years of
age (2).
Osteoporosis is the most prevalent metabolic bone disorder in the United
States (3). The National Institutes of Health Consensus Development Panel on
Osteoporosis Prevention , Diagnosis , and Therapy reported that in the United States ,
10 million people have osteoporosis and 18 million more have low BMD (8). The
third National Health and Nutrition Examination Survey (NHANES III) reported that
34-50% of postmenopausal women have osteopenia, a decrease in calcification of
density of bone, and 17-20% have osteoporosis (7). By ages 60 to 70 years, only 1 in
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9 women in the United States have defined normal BMD. Moreover, 1 in 3 women
have defined osteoporosis (2) . The World Health Organization defines the disease
state of osteopenia as having a BMD of 1 to 2.5 SDs below the young-adult mean (2).
Both osteopenia and osteoporosis increase fracture risk, although osteoporosis has the
greater impact (7). A 1 SD reduction in BMD may account for a 50-100% increase in
nonspine fractures (5). More than half of all women and nearly one third of all men
will experience an osteoporotic related fracture during their lifetime (2).
Approx imatel y 1 in 12 men will sustain an osteoporotic related fracture in their
lifetime (9). One in six Caucasian women will sustain a hip fracture during their
lifetime ( 10, 11). The incidence of hip fracture exponentially increases after 50 years
of age (2, 12, 13). After age 50, the incidence ratio of hip fractures in women to men
i approx imately 2 to 1 ( 1). The lifetime risk of sustaining a hip fracture has been

estimate d at 17% for Caucasian women and 6% for Caucasian men in the United
States (14). In the United States, approximately 55% of all hip fractures occur among
people 80 years of age and older. Of that percentage, approximately 33% occur after
the age of 85 years (2).
There are two classifications of osteoporosis, type 1 osteoporosis also referred
to as menopausal and type 2 osteoporosis also referred to as senile osteoporosis
(4,5,8). Type 1 osteoporosis is related to estrogen deficiency after menopause (3).
Type 1 osteoporosis is typically observed in women less than 65 years of age
affecting 5-25% of early post-menopausal women (5). Type 2 osteoporosis is
observed in both women and men with a ratio of 2 women for every 1 man
approximately 75 years of age or older (3). Once peak bone mass has been attained ,
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the prevalence of a bone loss pattern in type 2 osteoporosis is universally observed
(5). Hip fractures a.re the main consequence of type 2 osteoporosis (3). The
incidence of hip fractures begins to rise when men reach their late 60s and parallels
the rise in women in their early 60s (15).
In 1995, the National Osteoporosis Foundation reported the a1mual cost of
osteoporotic fractures to be about $13. 8 billion (7). This amount is expected to
double over the next 25 years due to increases in the elderly population (7). The
projected total cost for hip fractures in the year 2050 is $131.5 billion (16). Half of
all health care costs attributed to hip fracture patients is used for nursing home
facilities (2). Nearly one third of all individuals who have sustained a hip fracture in
the last year will be discharged to a nursing home (8). When men sustain a hip
fraclure , the mortality rate is higher than that of women (15, 17, 18). During the first
year after sustaining a hip fracture, the mortality rate is 36% for men and 21 % for
women (7). Mortality after sustaining a hip fracture may be a marker of underlying
disease states ( 19).
The majority of osteoporotic fractures in the elderly population are due to
minor to moderate trauma that typically would not occur in younger adult
populations. Mild to moderate trauma resulting in a fracture is defined as a fall from
standing height or lower (2). Approximately 90% of the elderly population that
experience a hip or wrist fracture in the United States is due to mild to moderate
trauma (2).
The spine is the most common osteoporotic fracture site (2). Due to a lack of
painful symptoms , only one-third of the vertebral fractures are diagnosed, and they
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dramatically increase after 65 years of age (2). Whenever a vertebral fracture
occurs , it is a strong indicator that additional vertebral fractures have, or will occur. It
has been reported that about 50% of women 80 years or older have vertebral
deformities due to previous vertebral fractures (2). Nearly half of all women with
vertebral fractures have two or more deformities (2).
The amrnal rate of hip fractures is predicated to triple by the year 2040 (2).
Functional disability greatly declines within the first year of a hip fracture (2).
Reduced functionality results in increased fall rates that further exacerbate
susceptibility for another hip fracture and lead to greater deterioration of physical
capacity (2).
The incidence of wrist fractures substantially increases an1ong women after
menopause , but levels off after 65 years of age (2). The plateau affect observed after
65 years of age may be due to the increased rate of older women falling forward on
outstretched hands (2). Women who have sustained wrist fractures have increased
hip fracture risks ( 10).
Several known risk factors (Table 1) for osteoporosis and associated hip
fracture risk include: cigarette smoking, low body weight (<127 lbs), tall stature,
estrogen, deficiency, low calcium intake, excessive alcohol intake, inadequate
physical activity, falls, various medications , chronic conditions, Caucasian race, age,
female gender, dementia, frailty, history of fracture in first-degree relatives, and
personal history of fractures (2,7,10, 11,12, 13). Some studies have reported lower
BMD and increased risk of fractures with cigarette smoking . Increased risk of
fractures also may be due to loss of low body weight increases the risk for hip
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fracture (2,5 ,7, l 0, 11,20,21).

Table 1. Risk Factors for Osteoporotic Hip Fractures
• Female sex
• Caucasian descent
• Increasing age
• Cigarette smoking
• Low body weight
• Tall statue
• Estrogen deficiency
• Low calcium intake
• Excessive alcohol intake
• Inadequate physical activity
• Medications (e.g. glucocorticosteroids , antiseizure medications, hormone
suppressants)
• Chronic conditions (e.g. thyroid disorders, diabetes mellitus , renal disease)
• Dementia
• Frailty
• History of fractures in first degree relatives
• Personal history of fractures

Low body weight also may result in low BMD and thereby increase fracture
risk (2). Low body weight has also been associated with preexisting conditions that
increase fracture risk (2). Decreased adipose tissue in the body cavity may decrease
endogenous estrogen activity, which then can lead to bone loss and increased fracture
risk (7 ,20,21 ,22). In addition, adipose tissue surrounding the femoral hip may not
provide suffic ient protection in leaner people. In the event of a fall, a loss of adipose
tissue can increase the risk of fracture (2,21,22). Moreover , it has been sugg ested that
the most consistent predictor of BMD is total body fat (22,23 ). Hence, greater total
body fat results in elevated BMD.
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Tall women have an increased risk of hip fracture (10, 11). The increased
fracture risk may be due to a longer hip-axis (10). Tall women also have a greater
distance to fall, which increases hip fracture risk (10).
Estrogen deficiency in premenopausal women or estrogen deficiency due to
menopause accelerates bone loss (2,4,24,25). BMD losses of 2-4% occur up to 5 to
10 years after menopause in the absence of estrogen replacement therapy (2).
Smoking is a significant risk factor for osteoporosis and hip fracture
(10, 15,26). Smoking increases the risk for osteoporosis by inducing premature
menopause. Smoking also causes increased metabolic breakdown of estrogen that
increases bone loss (5). Estrogen breakdown increases bone remodeling and
osteoclastic activity (27). Orwoll et al. (28) reported smoking in men 60 years of age
and older was associated with lower BMD (28).
Excessive alcohol intake is a strong risk factor for bone loss and fractures
(2, 15). Excessive alcohol intake may impair osteoblastic activity. Furthermore, high
consumption of alcohol may lead to protein and/or calcium malnutrition, reduced
mobility , and hypogonadism (5). Clu-onic alcohol use may increase fracture risk due
to increased fall rates and hepatic disease (2). Hepatic encephalopathy, resulting in
decreased cognitive ability, may lead to increased fall rates as a result of decreased
functionality and cognitive capacity.
Sedentary living is a strong risk factor for bone loss and fractures (2, 7, 10,22).
Physical activity , in particular bone building exercises , help to maintain or possibly
increase BMD and thereby reduce fracture risk (29,30). Epidemiological studies have
sugge sted that hip fracture risk decreases by 20% to 50% for physically active adults
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compared to sedentary adults in the United States (31 ). Even after attainment of
peak bone mass, bone tissue can adapt to mechanical loading promoting bone
remodeling. If physical activity is absent , then reduction in bone mass often ensues
(30 ,31). Other possible benefits of physical activity may include improved agility
and coordination , as well as increased muscle strength that may lower the likelihood
of experiencing a fall , and therefore reducing fracture risk (2,29,30,32).
Increased fall rates may largely affect hip fracture risk rather than vertebral
fracture risk (2). Vertebral fractures primarily occur spontaneously from bone
deterioration and low BMD, combined with minimal trauma of low impact forces
such as bending or lifting (2). Fall mechanics may play a role in the etiology of hip
fracture . Falls to the side with impact to the hip or side of the leg increases hip
fracture risk (33).
African American women, Hispanic women, and Asian women have a lower
fall incidence compared to Caucasian women (1,2). Nearly 20% of Caucasian
women 60-64 years of age and 30% of Caucasian women 80-84 years of age fall
ammally (2). Hip fractures occur twice as often in Caucasian women compared to
African American , Asian , and Hispanic women (2). It appears however , that of the
Hispanic subgroup populations, Mexican Americans have the highest hip fracture risk
although hip fracture incidence rate is lower than Caucasians (34) . The lower hip
fracture incidence in African Americans may be due to overall high BMD levels (2).
Lower hip fracture risk in the Japanese populations is most likely related to lower fall
rates as well as different femoral hip geometry compared to other populations (2).
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Long-term usage of corticosteroids may result in decreased BMD and
increased fracture risk (2). Fitzpatrick (35) reported that BMD is reduced 40-60% in
patients with endogenous glucocorticoid excess and pathologic fractures have been
observed in 16-67% of the patients (35) . In addition, hip fracture risk doubled in the
glucocorticoid treated patients (35). Glucocorticoid induced bone resorption may
also be in part due to secondary hyperparathyroidism and hypogonadism (15,35).
Long-term elevation of parathyroid hormone (PTH) levels increases osteoclast bone
resorption (35,36). Furthermore, glucocorticoid therapy inhibits insulin-like growth
factor (IGF) synthesis. IGF-1 is synthesized by bone cells and stimulates bone cell
replication and collagen synthesis (35,37 ,38). Glucocorticoids may also affect IGFbinding proteins leading to inhibition ofIGF activity. Glucocorticoid therapy may
give an overall effect to reduce bone formation by decreasing IGF-binding protein 3,
IGF-binding protein 4, and IGF-binding protein 5 (35).
Anticonvulsants and other medications may also contribute to bone loss.
Drug interactions and the conditions for which certain drugs are prescribed also
impact bone mass (2). Bone disease associated with convulsant therapy may lead to
high-turnover osteoporosis. Furthermore, seizure episodes may increase hip fracture
risk (35).
Chronic health conditions contribute to poor bone health. Low body weight is
a strong risk factor for hip fractures and may be a consequence of chronic disease
(2,3, 10, 11). Several disease states associated with bone loss and fracture incidence
include hypogonadism, renal disease, dementia and cognitive impairment,
cardiovascular disease , diabetes mellitus, stroke, hyperthyroidism , and
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hyperparathyroidism (2,3,39). Both hyperthyro idism and hyperparath yroi disrn can
stimul ate bone formatio n as well as bone resorption (4,35,36). Consequently, if
osteob lastic cells are not significantly respo nsive , bone loss may occur. Ahmed et al.
( 12) reported increased fracture risk in women with hypothyroidism or
hyperthyroidism (12). Secondary hyperparath yro idism can be caused by intestinal
malabsorption and renal disease associated with vitamin D metabolism impairment
( 15,36,40,41).
PTH levels increases with age and is present in higher concentrations in the
elderly and those persons who have previously sustained hip fractures. Increased
PTH leve ls may result in increased bone turnover (40,42). Furthermore, low serum
25-hydroxyvita min D levels are often observed in the elderly population are often
assoc iated with high serum PTH levels. Higher leve ls may accelerate bone loss and
thereby increas e hip fracture risk (36).
Aluminum induced osteomalacia may be observed in hemodialy sis patients
(35). Aluminum inhibits bone mineralization and phosphate absorption. Aluminum
induced osteomalacia may increase serum phosphate levels and lower 1,25dihydroxyvitamin D levels (35).
Cummings et al. ( 10) reported that a woman, whose mother sustained a hip
fracture, especially before 80 years of age, doubled the likelihood of sustaining a hip
fracture during her lifetime compared to controls (10). The increased hip fracture risk
was independent of BMD , weight, and height (10).
It has been rep01ted that genetics accounts for 50-60% of peak bone mass

( 15, 17). Seeman (27) reported that twin studies and family member studies have
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found that differences in bone size, shape, and BMD of individuals of the same age
are likely due to genetic rather than environmental differences , although no genes
have been consistently shown to account for the differences (1,27). It has been
suggested that several genes rather than one or two genes with major effects account
for bone mas s regulation (1). Seeman (27) stated that the inconsistencies may be due
to poorly defined phenotypes, and that fractures are too rare to define an association
of genes to bone size, shape, and BMD (27).
Fractures have been associated with lower BMD (28). And, a previous history
of fractures has been associated with an increased risk for future fractures (2,41 ,43).
Adults who sustain a fracture , are 50 % to 100% more likely to sustain a subsequent
fracture (14). The risk of a future fracture increases 2 to 3 times for each previous
fracture (2). Ross (2) stated that among women greater than 80 years of age who had
a history of wrist fractures, 30% of those women subsequently experienced a hip
fracture during their lifetime (2).

Diabetes Mellitus
Diabetes mellitus is defined as a heterogeneous group of conditions
represented by increased serum glucose concentrations , carbohydrate, fat, and protein
metabolism abnormalities, and the propensity to develop marked, specific forms of
renal , ocular , neurologic , and premature cardiovascular diseases (44,45,46). The
exact pathogenesis and etiology of diabetes mellitus is not known (44 ,45,46).
Conditional diagnosis of diabetes is made with a normal fasting plasma glucose
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(FPG) level greater than 7.0 1m11ol/L(126 mg/dL) (44,45,46,47). It is
recommended that FPG be tested different days to confirm diagnosis of diabetes
( 44 ,45 ,46).
Although the classification of diabetes type may be unclear due to definition
over -lap , it falls into several general types: type 1 diabetes and idiopathic type 1
diabetes, type 2 diabetes , gestational diabetes , and other specific types of diabetes that
are considered primarily risk factors for another diabetes type (46).
Type 1 diabetes is an immunologicall y mediated and genetically linked
disorder (41 ). Genetic predisposition to type 1 diabetes is strongly associated with

HLA-DQ and DR on the short arm of chromosome 6 (45). Furthermore, the insulin
gene on chromosome 11 and the cytotoxic I-lymphocyte antigen gene on
chromosome 2 may be associated with type 1 diabetes (44,45). Approximately 60%
of the genetic susceptibility to type 1 diabetes is thought to be related to HLA genes
( 46). However, at least 11 other loci have been reported to be involved , with nearly
10% of the genetic predisposition being accounted for by the flanking region of the
insulin gene on chromosome 11 (45) .
The pathogenesis of type 1 diabetes may result from autoimmunity reflected
by autoimmunity reflected by autoantibodies against insulin (44). Approximately 9095% of type 1 diabetics have antibodies against one or more pancreatic beta cell islet
components (45). Moreover, 3.5-4% of first-degree relatives without type 1 diabetes
also have circulating antibodies (45) . The pathophysiology behind type 1 diabetes
involves total destruction of the pancreatic beta cells resulting in complete
dependence on exogenous insulin (44) .
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Typ e 1 diab etes usually occurs before 30 years of age (44,45). The annual
incid ence rate of type l diabetes is l 8.2 cases / 100 ,000 people under the age of 20
(45). Incid ence rate is lower in African Americans, Hispanic s, Asian Americans, and
American Indi ans as compared to Caucasians (45). The annual prevalence rate of
type l diabetes is l case /590 people under the age of 20 (45). Approximately 5- 10%
of people with diabetes have type 1 diabete s (44 ,45,46 ). The clinical signs and
sympto ms identified in type l diabetics prior to the presentation of type 1 diabete s
includ e: polyuria , polydipsia, fatigue, polyphagia , blurred vision, persistent
hyperglyce mia , dehydration , ketoacidosis , significant weight loss, irritability , and
fat igue (45).
Type 2 diabete s is the most common type of diab etes and accounts for about
90% of diabetic patients in the United States (44,45,46). Type 2 diabete s is a
heteroge neou s disease of unknown etiology primarily manifested through
enviromne ntal factors that may interact with susceptibility genes (45 ,46). Genetic
suscep tibility to type 2 diab etes is enhanced through enviro1U11entalfactors such as
seden tary living and obesity (45 ,46). A type 2 diabetic with polyge nic defects are
manifested via insulin deficiency, impair ed beta cell insulin secretion, and visceral
obesity (45) . The developm ent of type 2 diabetes involves reduced cellular insulin
secret ion, diminished liver , muscle , and adipose tissue sensitivity to insulin , and
impaired insulin action that cannot compensate for increased serum glucose
concentrations (45,46,48).
Type 2 diabetes is multifactorial and requires both enviro1m1ental and genetic
factors (46 ,49). A type 2 diabetic phenot ype can develop in persons with normal
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insulin sensitivity who have a monogenic defect that impairs beta cell function or
in persons who have one of severa l polygenic defects in which obesity, insulin
resistance , and impaired beta cell insulin secretition are all part of the altered
metabolic state (49). Approximately 85% of the diabetic population has polygenic
defects (49). Moreover , environmental conditions can influence both monogenic and
polygenic defects (49).
A treatment regimen to control serum glucose levels must be administered
(45,46). Personalized treatment will depend on the age of the patient, years of

ant icipated survival, other health conditions, and the compliance of the patient to
specific treatment regimens (45,46). Diet therapy alone or concomitantly used with
ora l pharmacological agents may be used as treatment to reduce hyperglycemia
(45 ,46). Over time , total exogenous insulin dependence may result (46). Although

type 2 diabetes can occur at any age, typ e 2 diabetes has been observed increasingly
among children as a consequence of the emerging epidemic of childhood obesity
(46).

Worldwide , the prevalence of diabetes is estimated to double within the next
25 years and will affect approximately 300 million people by the year 2025 (46).
More than 80% of the estimated 300 million people will suffer from type 2 diabetes
(46) . Chronic diabetes often leads to serious medical complications.

Retinopathy ,

neplu·opathy , and neuropathy are long-term complications of diabetes and may be
indicators of diabetes severity and poor glycemic control (44,45,46).
Retinopathy affects greater than 6 out of 10 type 1 diabetics (46). It is
estimated that 70-100% of type 1 diabetic s acquire retinopathy (50). In addition, 60 %
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of type 2 diabetics experience some degree of retinopathy (51). Retinopathy is
normally observed in type 2 diabetics having the disease for more than 20 years
(44,46). There are two types of retinopathy associated with diabetes: nonproliferative
and proliferative (46,51). Nonproliferative is considered a mild form of retinopathy
and is also the most common form of retinopathy. Nonproliferative retinopathy
occurs when blood vessels in the retina become weak and swelling resulting in
bulging or fatty deposition of the vessels (46). Nonproliferative retinopathy does not
cause visual disturbances unless associated with macular edema (44,45). Proliferative
retinopathy occurs when blood vessels in the retina become damaged resulting in
bleeding and closing off of microaneurysms and hard exudates (44,45,46). Moreover,
the retina may compensate with new blood vessels, or they may in turn bleed. If
heavy bleeding results or if bleeding occurs in certain areas of the eye, vision may be
altered or impaired. New blood vessels can also form scar tissue that can push or pull
on the retina distorting vision (46).
The diabetic person is twenty times more likely to develop nephropathy than a
person without diabetes (46). Greater than 3 out of 10 people with type 1 diabetes
and nearly 1 in 10 people with type 2 diabetes will experience nephropathy (46).
Nephropathy is characterized by proteinuria, hypertension, edema, and renal
insufficiency (45) . Nephropathy can lead to kidney failure . In the United States,
diabetes is the leading cause of kidney failure (46). Kidney failure is four times more
common in African Americans with diabetes than in Caucasians with diabetes (46).
ln addition, kidney failure is four to six times more common in Hispanics and six
times more common in American Indians with diabetes than in Caucasians with
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diabetes (46). It may be that African Americans, Hispanics, and American Indians
experience kidney failure secondary to diabetes at a higher ratio than Caucasian
Americans, due to the higher prevalence rate of diabetes (46). Approximately

40% of

people beginning dialysis in the United States has diabetes (45). Of that percentage
group, half have type 1 diabetes (45).
Diabetes is an independent risk factor for peripheral neuropathy (52). High
serum glucose levels can damage nerves by weakening capillary walls that nourish
nerves, which then can lead to neuropathy (46). Depending on the degree and
severity of neuropathy , gastroparesis, peripheral neuropathy, and urinary incontinence
and dysfunction secondary to a neurogenic bladder, etc. can occur (44,46).

Sensory

nerve damage of the feet may lead to loss of sensation in the feet, which then may
lead to ulcerations and infections of the feet. In addition, high serum glucose levels
can reduce blood circulation to the feet by arterial constriction and vascular
insufficiency thus impairing wound healing. If ulcerations of the feet are left
untreated, foot amputations often result (44,45 ,46). Approximately

60,000 foot

amputations are pe1formed annually in the United States (46).
Other complications of diabetes resulting from blood vessel damage are
coronary artery disease and stroke (44,46,52,53,54).

Type 2 diabetes is an

independent risk factor for macrovascular disease (44,55). Vessel damage incurred
by high serum glucose levels increases the risk for arterial plaque formation.

Vessel

damage also increases arterial pressure leading to reduced blood circulation (44,46).
Coronary heart disease alone is the direct cause of 77 ,000 deaths annually in the
United States among people with diabetes (46). Cerebrovascular

accidents affect
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400,000 people in the United States annually. Of which, 25 % do not survive the
incident (52) .
Although the exact etiology of the pathogenesis of type 1 diabetes and type 2
diabetes in unclear, there are several factors that increase risk of developing diabetes.
The chance of acquiring type 1 diabetes or type 2 diabetes increases if a family
member has type 1 diabetes or type 2 diabetes (45,46). For example , if one identical
twin develops diabetes, the likelihood of the other twin developing diabetes is 2550% (45). This risk or developing diabetes for the other twin is in contrast to a 0.4%
risk in the general population , a 15% risk to a human leukocyte antigen (HLA)
identical sibling , and a 1% risk in an HLA nonidentical sibling (45).
Exces s body weight is a strong risk factor for developing type 2 diabetes
(32, 45 ,46 ,56,57). Greater than 8 out of 10 persons with type 2 diabetes are
con sidered overweight (46) . The higher the proportion of fatty tissue in the body , the
greater the resistance to insulin muscle and tissue cells experience (46 ,5 8). Moreover
the insulin resistance phenomenon is increased when excess visceral fatty tissue is
concentrated in the abdomen area (46,58). However , persons with type 2 diabetes can
improve serum glucose levels by moderate weight loss (46).
Sedentary living is considered a risk factor for type 2 diabetes (32,46,56).
About 70% of adults in the United States either do not engage in any physically
activity or are considered sedentary (59) . Physical activity aids in maintaining
appropriate body weights, utili zing serum glucose in the form of energy , sensitizing
muscle and tissue cells to insulin, increasing blood flow and vessel circulation, and
increasing muscle mass (32,46). In nom1al conditions , approximately 70-90% of
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serum glucose is absorbed in muscle tissue (46). Consequently, lack of physical
activity may lead to reduced muscle mass and hence, impaired serum glucose
absorption in muscle tissue. Physical activity, independent of obesity, has been
shown to decrease the risk for type 2 diabetes (59).
The likelihood of acquiring type 2 diabetes increases with age. Most notably ,
after the age of 45, the risk of developing type 2 diabetes increases (46). It is
estimated that 1 in 5 Americans older than 65 years of age have type 2 diabetes (46).
The increased risk of developing type 2 diabetes as people age may be partly due to
less engage ment in physical activity and hence, less muscle mass, and weight gain
(46).
Type 2 diabetes is more apparent in Hispanic, African American, and
American Indian populations in the United States (44). Furthermore, type 1 diabetes
is more common in Caucasians in the Unite d States as well as in European countries
(45,46). The etiology of etlmicity and risk for developing diabetes is unclear (46). It
may be that the etiology of ethnicity and diabetes is multifactorial.

Diabetes Mellitus and Osteoporotic Hip Fractures

Prior studies have not established a consistent association between
osteoporotic hip fracture risk and diabetes mellitus (60). One reason for this is the
limited amount of research conducted in this area. Until more data is gathered, debate
will continue on the association between diabetes and osteoporotic hip fractures. One
possible reason for Jack of association is insufficient data on bone mineral density
(BMD) and the risk of osteoporosis in type 1 and type 2 diabetic patients (61). Due to
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pathogenic differences in the onset and ph ysiology of type 1 and type 2 diabete s,
BMD statu s has often, but not always, supported different findings between type 1
and type 2 diabetic patient s (6 1). Type 1 diabetes has long been assoc iated with low
BMD (7,39,61 ,62,63,64,65,66). However , data on the relationship between type 2
diabetes and BMD has not generated conclu sive findin gs (6 1,63,65,66).
Heterogeneity of stud y participants , patient popu lations studied, measurement and
study techniques , and inappropriate control groups or absence of control groups may
accou nt for some of the inconclusive results previousl y reported (63,65). Some
studi es have found similar or higher BMD in type 2 diabetes compared to nondi abetic
control subject s (2,6 1,63,64,65,6 7).
Differences in BMD leve ls betw een diabetic patients and controls have been
atlrib uted to severa l factors (Table 2). Lower BMD in type 1 diabetes versu s type 2
diabetes could result from rapid bone loss after the onset of type 1 diabetes, reduced
peak bone mass, increased bone loss preceding peak bone mass , or a common
genotype that make s type l diabetic s more susceptible to low BMD (61,68). Type 1
diabetics may experience high rates of bon e turnover and resorption that may be
attributed to secondary hyperparathyroidism , hypomagnesemia , and decreased leve ls
of 1-25-hydroxycholecalciferol

(10,15,40,69,70).
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Table 2. BMD and Diabetes Me llitu s
Type 1 Diabetes
• Rapid bone loss after onset of
diabetes
• Reduced peak bone mass

•

•
•
•

Increased bone loss after
attainment of peak bone mass
Common genotype lowering
BMD

•
•
•

•

Type 2 Diabetes
Insulin resistance before onset of
diabetes may improve BMD
High endogenous insulin may
improve BMD
Lower BMD with increased
duration of type 2 diabetes
Increased BMD in type 2
diabetics with excessive body
weight

Lower BMD with increased
duration of typel diabetes
Menstrual disorders and/or early
menopause mav decrease BMD

Elevated BMD levels observed in type 2 diab etics may be due to the period of
insulin resistance before the onset of diabetes , which promotes hyperin sulinemia
(63,66). High endogenous insulin levels may improve BMD (37). Hyperinsulinemia
may also lead to increa sed BMD via its ne gative effect on sex hormone binding
globuli n (63).

Furthermore, obesity has been associated with increased BMD (37).

It may be that one possible reason for the association between obesity and BMD is
due to the po sitive relationship between obesity and elevated endogenous insulin
levels (37). Obesity has also been associated with increased BMD due to increased
adipose tissue s that produce estrogen (66,70). Bone turnover in type 2 diabetics with
appropr iate glycemic control has been reported to be equal to or lower than bone
turnover in persons without diabetes . Consequent ly, some studies have reported
higher bone mass in type 2 diabetics than in nondiabetic controls (70).
Insulin may act directly on bone tissue or insulin may work indirectly by
binding to the insulin-like growth factor (IGF-1) receptor (63,65). In vitro studies
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have demonstrated that insulin stimulates osteoblast cell proliferation involved in
bone formation (37,65). Some cross-sectional studies have observed a positive
association between BMD and insulin (37). In addition, the structural similarity
between insulin and I GF-1 may play an important role in stimulating bone formation.
I GF-1 is a polypeptide synthesized by bone cells and appears to regulate bone
formation (35 ,37,38). Other cytokines and cellular messengers may also influence
bone metabolism (63). Nonetheless, the duration of diabetes plays a critical role in
increasing the risk of hip fracture given the lower BMD levels found among patients
who have had diabetes for greater than 5 years (63).
Age of menarche and menopause plays a key role in bone formation and
osteoporosis in women (71 ). Approximately 30% of type 1 diabetic women report
amenorrhea, polymenorrhea , and oligomenonhea throughout their reproductive years.
This is double the prevalence of menstrual disorders observed among women without
type 1 diabetes and, the differences are most pronounced when the onset of type 1
diabetes is prepubescent. Menstrual disorders may result in lower BMD (11 ,22) . In
addition, type 1 diabetes may promote early menopause causing lower BMD due to
reduced levels of endogenous estrogen (71).
Estrogen replacement therapy has been shown to lower the risk of
osteoporosis development (2,4,22,24,25,72).

However , postmenopausal estrogen use

may influence carbohydrate metabolism and may be associated with type 2 diabetes
(73). Some studies have reported no increase in incidence of type 2 diabetes with
postmenopausal estrogen use (67,68). Other studies reported by Zhang et al. (73)
have shown that estrogen was associated with lower fasting glucose and insulin
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levels , but estrogen's use was related to a rise in 2-hour insulin and glucose levels
(73). Zhang et al. (73) suggested that postmenopausal estrogen use may relate to
deterioration of glucose tolerance and that longer usage of postmenopausal estrogen
among current users may increase the risk for type 2 diabetes (72). Wilson et al. (72)
reported that laboratory research conducted on ovariectomized rats with reduced
estroge n levels foster insulin resistance. Yet, estrogen treatment administered to the
rats restored insulin sensitivity. Furthermore, juvenile rats undergoing estrogen
withdrawal experienced augmented fasting and glucose stimulated insulin levels (72).
Some studies have also reported that estrogen replacement therapy may be associated
with less insulin resistance in postmenopausal women with type 2 diabetes (72). Yet,
postmenopausal estrogen use may be more common among leaner women (57).
Hyperparathyroidism has been associated with decreased BMD (2, 7). Grey et
al. (58) showed that postmenopausal women with primary hyperparathyroidism were
significantly heavier , had a greater total body fat mass, and had proportionately more
android fat than age-matched, eucalcemic controls (58). After adjustment for body
weight, there remained modest bone mass reductions in the postmenopausal women
with primary hyperparathyroidism (58).
Primary hyperparathyroidism may lead to insulin resistance by promoting
increased adiposity by select ively affecting skeletal muscle and not adipose tissue,
thereby diverting carbohydrate to adipocytes (23,58). Insulin resistance may also
occur due to the influence of the parathyroid hormone on adipocyte differentiation
and function (58). Finally, insulin resistance may occur via the effects of obesity on
calcium metabolism leading to secondary byperparathyroidism (58,74). Obesity
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increase s the risk of developing type 2 diabetes (32,44 ,46,56,57) . In addition ,
hyperparathyroidism has been associated with diabetes (75,76).

It has also been reported that bisphosphonates may increase BMD in type 2
diabetic persons via apoptosis of osteoclast cells, reduced osteoclastic recruitment,
and inhibition of osteoclastgenesis resulting in decreased bone resorption (66).
Chung et al. (66,77) suggested that HMG-CoA reductase inhibitors increase new
bone formation in skeletal tissue by osteoblasts in both in vitro cell culture systems
and in vivo mice experiments (66,77). A proposed mechanism for bone formation
involves an increase in expression and synthesis of bone morphogenetic protein 2 that
may play a role in fracture repair and bone regeneration (66,77).
Factors other than BMD may also impact hip fracture risk (Table 3). Diabetes
is associated with increased disability in postmenopau sal women (2,78). Physical
disability , loss of independence , and diminished quality of life may increase hip
fracture risk (78). Greater than 50% of older people with diabetes have reported
some degree of physical disability (78). Functional disability may lead to further
complication s of diabetes including hyperglycemia, obesity, cardiovascular disease ,
peripheral vascular disease , depression , arthritis, and limited physical activity (78). It
is possible that diabetic complications have a direct impact on hip fracture risk.
Osteoporosis associated with type 1 diabetes and type 2 diabetes is worse in people
with poor glycemic control (3,63,79). Poor glycemic control may result in
hypercalciuria leading to negative calcium balance and secondary
hyperparathyroidism.

Consequently , bone resorption and bone loss may ensue (79).
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Table 3 Diabetes Mellitus and Its Complica ions May Increase Hip Fracture Risk
Type l Diabetes
Type 2 Diabetes
• Physical disability
• Physical activity
• Loss of independence
• Loss of independence
• Decreased quality of life
• Decreased quality of life
• Hyperglycemia
• Hyperglycemia
• Hypoglycemia
• Hypoglycemia
• Cardiovascular disease
• Car diovascu lar disease
• Peripheral vascular disease
• Peripheral vascular disease
• Depression
• Depression
• Arthritis
• Art hriti s
• Incre ased low-impact fall rates
• Increased low-impact fall rates
• Decreased neurological activity
• Decreased neurological activity
• Visua l imp airment
• Visual impairment
• Poor glycemic contro l
• Poor glycemic contro l
• Polyuria and nocturia
• Polyuria and nocturia
• Hyperparathyroidism
• Hyperparathyroidism
• Thyrotoxicosis
• Sedentary life style

Thirty percent of the conununity-dwelling elderly pop ulation in developed
countries fall at least once a year and 10-20% fall twice or more (29). The effect of
elevated fall frequency and the fact that over 30% of elderly women have
osteoporosis has led to increased rates of osteoporotic fractures with increasing age
(29,80) . Approximate ly 90% of hip fractures result from falling (14,80) . Diabetic
patients may be at increased risk of falls and consequently increased risk for hip
fracture (2,29,39,81,82,83,84). Increased fall rates may be due to hypoglycemic
episodes (84). Kennedy et al. (84) reported that diabetic patients treated with insulin
therapy were at increased hip fracture risk possibly due to hypoglycemic m echanism s
(84). Hypoglycemia can impair visual acuity, which may lead to increa sed fa ll
incidence (7). Some studies have suggested that physical activity and certain
regimens , such as weig ht-b eari ng activities , may reduce the risk for fa llin g
(2,28,29,30,32).

Weig ht-b earing activity in older and frai l persons impro ves muscle
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strength and mobility (29,30). Yet, physical activity may increase risk for falls due
to skeletal muscle movement that displaces the body's center of gravity (29). In
particular, vigorous physical activity , especially in the elderly and those with
functional disabilities, may yield the highest risk for fall-related fractures (31 ).
Physical activity has long been associated with increasing insulin sensitivity
and decreasing abdominal adiposity and fat deposition (32). A sedentary lifestyle is
considered a major risk factor for type 2 diabetes (7,32) . Neurologic , vascular, and
ophthalmic complications due to diabetes severity have also been shown to increase
fall rates as well as hip fracture risk (7, 84).
Diabetic retinopathy is the third leading cause of blindness (82). In addition,
diabetes is the leading cause of adult blindness in the United Sates (43,44). Diabetic
retinopathy leads to visual impairment and predisposition to falls and hip fractures
(2 ,7 ,10,68 ,82). Yet, Ivers et al. (64) found that even after adjustment for visual
impairment, their data concluded that there remained a significant association
between diabetic retinopathy and hip fracture risk (64). The only proven prevention
of diabetic retinopathy is strict glycemic control. Even then, about 12% of diabetics
still develop retinopathy when following strict glycemic treatment (50). Diabetic
related visual disability may increase noncompliance of diabetic patients to treatment
regimen, difficulties in self-administration of insulin and oral pharmacological
treatments , difficulties in glucose monitoring, and inability to self-screen for diabetic
complications such as foot ulceration (82). Such problems, exacerbated by visual
impairment, may have a profound impact on glucose control, disease burden, and
consequently hip fracture risk. Ivers et al. (64) reported an increased risk of fracture
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with diabetic retinopathy, advanced cataract, longer diabetes duration, and insulin
treatment compliance (64). To complicate matters further, Schaumberg et al. (83)
reported risk of cataract increased in persons with higher body mass indexes, taller
persons, and persons with greater amounts of abdominal adiposity (83). Higher body
mass indexes and greater amounts of abdominal adiposity are associated with
development of type 2 diabetes (6,32,46,56).
There appears to be a relationship between duration of diabetes and poorer
vision due to retinopathy and cataract formation (7 ,64,82). Fifty percent of
Americans aged 65 to 74 years of age have some form of cataract (51). Cataract can
lead to simulation affecting distance vision, glare related vision loss, and contrast
difficulty (51). Thus , cataract development in diabetes persons may lead to increased
fall rates due to vision impairment.
The EURODOAB Prospective Complications Study showed that retinopathy
developed in 56 % of diabetics within 7 years. Incidence of retinopathy peaked
between 10 and 20 years of baseline diabetes duration (50). The impact of diabetic
retinopathy on hip fracture risk may be more pronounced in diabetic patients with an
early onset of the disease due to increased overall incidence of cataract and
retinopathy (64,82).
Peripheral neuropathy frequently occurs in the diabetic population and is the
leading cause of peripheral neuropathy in developed nations (2,84,85). Peripheral
neuropathy increases foot ulceration and lesions (7,52 ,84,86). Not only does
peripheral neuropathy increase foot ulceration and lesions, but also motor and sensory
neuropathy predisposes the patient to infection (52). Consequently , infection may in
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turn lead to further exacerbation of food ulceration and lesions. Peripheral artery
disease leads to increased risk of disability and physical functioning (78, 79,86).
Impaired physical functioning, in particular lower extremity functioning, leads to
increased fall rates and hence, increased hip fracture risk. Peripheral neuropathy
alters coordination and balance, resulting in reduced gait and decreased reflexes
(2,68,80,81,86). Another complication that may be present when alterations occur in
gait and balance is polyuria and nocturia , which may also increase the risk of falling
(7) . Some studies have also reported that peripheral artery disease in diabetics
progresses at a faster rate than in nondiabetics with peripheral artery disease (84).
Two common endocrine problems in the diabetic population that may lead to
osteoporosis include thyrotoxicosis and hyperparathyroidism (75,76).
Thyrotoxicosis , namely Grave's disease, develops after the onset of diabetes in type 1
diabetic patients. The development of thyrotoxicosis increases with age and primarily
occurs in postmenopausal women. Thyrotoxicosis has been suggested to be a cause
of osteoporosis (75,76). Furthermore, persons with Grave's disease and type 1
diabetes have been reported to share a common HLA genotype (76).
Hyperparathyroidism occurs with nearly the same frequency in type 1 as type 2
diabetics. Autoimmune hyperthyroidism is more common in type 1 diabetics and
may be responsible for lower BMD in type 1 diabetic patients (76). Secondary
hyperparathyroidism , hypomagnesaemia, and decreased levels of 1-25hydroxycholecalciferol may increase bone turnover and bone resorpt ion in type 1
diabetics (10, 15,40,69, 70).
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One of the primary risk factors for type 2 diabetics is obesity (7,44,46,70).
Obese postmenopausal women have higher endogenous estrogen production and
lower levels of sex hormone binding globulin that can increase BMD and lower hip
fracture risk (11,65). Larger muscle in obese persons requires more work to move
body mass, which may stimulate bone formation (11 ). Excess adipose tissue
surrounding the femoral hip may serve as a protector in the act of a fall and therefore
reduce the risk for hip fracture (11).
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RESEARCH OBJECTIVE

The objective of this study was to establish a relationship between type 2
diabetes mellitus and osteoporotic hip fractures. Therefore, the hypothesis that was
tested is that type 2 diabetes is associated with increased risk of osteoporotic hip
fracture.
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MATERIALS AND METHODS

Data Collection

The Utah Study of Nutrition and Bone Health (USNBH) is a case-control study
conducted in Utah during 1991-2001 to determine risk factors for osteoporotic hip
fracture. All study participants were determined from Utah residents aged 50-90
years. The average age was 76.36 (n= l 779) for females and 74.21 (n=811) males ,
respectively. Age (within 5 years of cases) and sex matched controls, whom at
baseline never had a hip fracture, were randomly selected from the Utah Drivers
License pool if less than 65 years of age and the Medicare databases if greater than 65
years of age. Cases were obtained from 18 Utah hospital databases to validate hip
fracture status. Interview-given questionnaires and picture-sort food frequency
questionnaires were administered to participants in the study. All variables used in
the statistical analysis were defined in the USNBH database obtained by the
questionnaires administered to USNBH participants at the time of the study.
Potential variables included, but were not limited to, age, gender, weight, height,
body mass index (weight in kg/height in m2), smoking status, estrogen use, alcohol
status , physical activity, intake of certain vitamins and minerals, cognitive function,
statin use, glucocorticoid steroids , economic status, education level, stroke,
cardiovascular disease , and thyroid function. Based upon this information,
independent variables were identified that could potentially affect the occurrence of
hip fracture. Specific variables selected for analysis were sex, body mass index (BMI)
calculated from participant reported weight and height , diabetes, smoking status ,
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alcohol usage , physical activity , education level , and estrogen use in women
subjects only. Type 2 diabetes participants were classified by the age of onset of
diabetes. Type 1 diabetes typically develops before 30-years-of-age (44,46).
Therefore, the age of 30 was the cut off point for the classification of diabetes type.
Greater than 30 years of age was used to distinguish type 2 diabetes. Type 1 patients
were dropped from the study because of insufficient numbers for statistical analyses
(n=l 0). Only the type 2 diabetic population was used in this study.
Potential participants with high impact trauma ( considered a fall from greater than
chair height or impact fractures sustained from vehicular accidents) and a low MiniMental State Examination (MMSE) score of less than or equal to 17 were excluded
from the data set (11=150).
Statistica l Analyses
Contingency tables were calculated and chi-square analysis was used to compare
the expected contingency table to the observed contingency table. Logistic regression
analysis and modeling techniques were used to determine the associations between
type 2 diabetes and hip fracture risk. Initially odds ratios were used to evaluate the
risk of hip fracture, and then the analyses were stratified by gender and BMI groups.
The dependent variable in the models was hip fracture which had two values,
fract=l (confirmed hip fracture) and fract=O (no hip fracture). The dependent
variable was binary (0 or 1). The independent variables were discrete in nature
instead of continuous.
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Because of the discrete natme of the data, the data was lo git transformed and
logistic regression analysis was used. The logistic regression model used in this study
was:
Ln {Y= [Prob(fract = l )]/[Prob(Fract=O)] }=BO+B1*XI +B2*X2+ ....... +Bn*Xn
The X's were the independent variables. The B's were the logistic regression
coefficients. Their estimates were represented by the b's. The B's represent the
original unknown parameter, while b was its estimate.
The left-hand side of this relationship is known as the logit transformation of a
probability. It is also called the log-odds ratio. The odds ratio gives the linear
relationship between the dependant variable and the independent variable.
All of the variates used in the statistical modeling were defined in the Utah Study
of Nutrition and Bone Health (USNBH) database obtained by from questionnaires
administered to USNBH participants at the time of the study. All statistical analyses
were conducted with SAS statistical software programs (SAS System Ver 8.02).
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RESULTS

As depicted in Table 4, hip fracture was not associated with education levels (p >
0.05) in both genders. Physical activity decreased the risk of hip fracture for women
(p < 0.0001) and for men (p = 0.001). Smoking status and alcohol use were
associated with the occurrence of hip fracture in women , but the association was not
significan t in men. Estrogen use decreased hip fracture risk in women (p < 0.0001) in
former or current users.
The risk of hip fracture was associated with type 2 diabetes. Among females, type
2 diabetes was more prevalent among cases vs. controls (15.6% vs. 11.7 %; p=0.02).
In the smaller number of men, the difference was similar (17.7% vs. 14.6%) but was
not significant. The significant correlation was primarily found in females in which
the risk of hip fracture increased accompanied with the onset of type 2 diabetes. As
indicated by the odd-ratios listed in Tables 5 and 6, the values of the odds-ratios for
either women or men were larger than one, indicating an increased risk of hip fracture
in people with type 2 diabetes. However, in males , there was a wide range of
variation for the odds-ratio, ranging from 0.9 to 2.0, which indicates that the
association of type 2 diabetes with hip fracture was most likely stronger in females
than in males , or that the smaller number of males resulted in lower statistical power
to detect a significant association.
Considering BMI, hip fracture risk showed different patterns with respect to
gender. In Table 7, females with a BMI larger than 30 had an odds-ratio of 2.0.
Females with a BMI between 25 to 30 had an odds-ratio of 1.3. This indicated that
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along with the increase of BMI, there was a significant association between hip
fracture and type 2 diabetes and an increase in hip fracture risk. On the contrary , in
Table 8, males with a BMI larger than 30 had the smallest odds-ratio of 0.8 compared
with males of the other groups , BMI < 25 and BMI between 25 to 30 with odd-ratios
of 1.2 and 1.7, respectively . Considering that a significant association between hip
fracture risk and type 2 diabetes was not found in males , a higher BMI in males could
have a protective effect against hip fracture .
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Tab le 4. Demographic and Lifesty le Characteristics of Cases and Contro ls by
Gender; The Utah Stud of Nutrition and Bone Health ; 1997-2001
Women

Age (mean in yrs , SD)
Weight (mean in kg, SD)
Height (mea n in m, SD)
Body mass index (mea n in
kg/n,2, SD)
Educatio n Level (N, %)
< 12 years
~ 12 yea r

Cases*
(N=882)
76.7(9. l )
63.5(14.1)
1.6 (0. 1)
24.2 (5.J)

460 (52 .2)
422 (47 .9)

Men
Controls*
(N=897)
76.0 (9.4)
68.7 (14.5)
1.6(0. l )
26.4 (5. 1)

454 (50.7)
442 (49 .3)

Cases*
(N=350)
74 .9 (9.5)
80.0 (14.8)
1.8 (0. 1)
25.0(4.1)

161 (46.0)
189 (54.0)

Contro ls*
(N=46 I)
73.7 ( l 0.7)
82.6 (] 5.2)
1.8(0.l)
26.4 (4.3)

204 (44.4)
256 (55.7)

Physical Activity Level** (N, %)
11 1 ( 12.4)
45 (] 2 .9)
None
220 (24.9)
41 (8.9)
186 (20.8)
111 (3 1.7)
One
24 1 (27.3)
10 1 (21.9)
363 (40.5)
118 (33.7)
19 1 (41.4)
Two
260 (29.5)
Three
16 1 ( 18.3)
236 (26.3)
76 (21.7)
128 (27.8)
p :S0.000 1
p S 0.001
Smok ing (N, %)
Never
750 (83.6)
158 (45.1)
682 (77.5
244 (2 .9)
Forme r
138 ( 15.7)
123 (13.7)
154(44.0)
179 (38.8)
24 (2.7)
Current
60 (6.8)
38 (] 0.9)
3 8 (8.2)
p S 0.075
p S 0.000 1
Alcohol Drinker (N, %)
7 13 (79.7)
154 (44.l)
226 (49. 1)
Never
636 (72.4)
8 1 (9.1)
114 (32.7)
128 (27.8)
133 ( 15.2)
Former
109 ( 12.4)
JOI (11.3)
8 1 (23.2)
106 (23 .0)
Current
p S 0.27
p S 0.0002
Estroge n Use (N, %)
Neve r
456 (53 .0)
386 (43.7)
228 (25.8)
Forme r
215 (25.0)
189 (22.0)
269 (30.5)
Current
p S 0.0001
Type 2 Diabetes (N, %)
740 (84.4)
789 (88.3)
288 (82.3)
392 (85.4)
No
105(]1.7)
62 (17 .7)
67( 14.6)
Yes
137 ( 15.6)
p S 0.23
p S 0.02
*Significant differences between cases and controls we re estab lished at p S 0.05 , p S 0 .01, and p S 0.000 1.
**Physical Activity is categorized by use of heavy housework, yard wo rk, or recreational act iv ity. Never,
one, two, and three are ass igned level s based on engagement in exactly none, one , two, or all thr ee types of
physical act ivities.
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Table 5. Risk of Hip Fracture Associated with Diabetes Status, Stratified by
Gender, U na d.1usted An ays1s
I .
Women
Status o f
Type 2
Diabetes

Type 2
Diabetic
Not Type 2
Diabetic

Men

Cases (N)

Controls (N)

137

105

Odds ratio
and 95%
confidence
interval
1.4

740

789

I. I - 1.8

Cases (N)

Controls (N)

62

67

Odds ratio
and 95%
confidence
interval
1.3

288

392

0 .8 - 1.9

Table 6. Risk of Hip Fracture Assoc iated with Diabetes Status, Stratified by Gender ,
Adjusted in Logistic Regression Models for Age, BMI, Physical Activity, Education
L eve,1 E strogen U se m
. W omen, Smo ki ng,a n dAl coh 0 1 U se
Women
Status of
Type 2
Diabetes

Type 2
Diabetic
Not Type 2
Diabetic

Men

Case s (N)

Controls (N)

137

105

Adjusted
odds ratio
and 95%
confidence
interval
l.7

740

789

1.3 - 2.4

Cases (N)

Controls (N)

62

67

Adjusted
odds ratio
and 95%
confidence
interval
l .4

288

392

0.9 - 2.0
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Table 7. Risk of Hip Fracture Associated with Diabetes Status for Women ,
Stratified by BMI; Adjusted in Logistic Regression Models for Age, Estrogen Use,
Physical Activity, Education Level, Smoking, and Alcohol Use
BMI < 25
(Wo men only)

Status of
Type 2
Diabetes
Cases
(N)

Type 2
Diabetic
Not Type 2
Diabetic

Adjusted
odds ratio
and 95%
confide nce
interval
1.5

Controls
(N)

49

25

473

362

BMI 25 - 30
(Wo men on ly)

0.9 - 2.7

Cases
(N)

Controls
(N)

44

37

190

260

Adjusted
odds ratio
and 95%
confide nce
interval
1.3
0.8 - 2.2

BMI > 30
(Women only)

Cases
(N)

Con trol s
(N)

37

40

Adjusted
odd ratio
and 95%
confidence
interval
2 .0

65

149

1.2 - 3.5

Table 8. Risk of Hip Fracture Associated with Diabetes Status for Men , Stratified by
BMI; Adjusted in Logistic Regression Models for Age , Physical Activity, Education
Leve 1 Smo k'mg , an d Al coh 0 1U se

Cases
(N)

Type 2
Diabetic
Not Type 2
Diabetic

BMI 25 - 30
(Me n only)

BMI < 25
(Men only)

Status of
Type 2
Diabetes

Controls
(N)

27

21

150

16 1

Adjusted
odds ratio
and 95%
confidence
interval
1.2
0.6-

2.2

26

24

Adjusted
odds ratio
and 95%
confidence
inter va l
1.7

102

172

0 .9 - 3.2

Cases
(N)

Controls
(N)

BMI > 30
(Men only)

9

21

Adjusted
odd ratio
and 95%
confidence
inter va l
0.8

31

57

0.3 -2.l

Cases
(N)

Co ntrol s
(N)
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DISCUSSION

This sh1dy supports the hypothesis that the risk of hip fracture is significantly
associated with type 2 diabetes. The significant association was found primarily in
females. This may be due to the higher number of female participants with type 2
diabetes and not a consequence of gender. However, the odds-ratios for both male
and fema les was greater than one, which indicates that type 2 diabetic s are at
increased risk for hip fracture. Yet, the odds-ratio trends still indicate a stronger risk
for type 2 diabetic females . These findings are in agreement with Nicodemus et al.
(70) who reported that type 2 diabetic women have increased hip fracture risk
compared to non-diabetic women (70). On the contrary, it has been reported that type
2 diabetic women have a lower frequency of sustaining a hip fracture (65) .
Furt hermore , F orsen et al. ( 60) found that type 2 diabetic women with a long duration
of the disease were at increased risk for hip fracture. However, type 2 diabetic men
with a shorter duration of the disease were found to have an in increase hip fracture
risk (60).
The findings also support previous research that physical activity decreases risk
for hip fracture. Sedentary living is a strong risk factor for bone loss and fractures
(2, 7, 10,22). Physical activity, in particular bone building exercises, help to maintain
or possible increase BMD and thereby reduce fracture risk (29 ,30). Epidemiological
studies have suggested that hip fracture risk decreases by 20% to 50% for physically
act ive adults compared to sedentary adults in the United States (31). Even after
achieving peak bone mass , bone tissue can adapt to mechanical loading promoting
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bone remodeling. If physical activity is absent, then reduction in bone mass often
ensues (30,31 ). Other possible benefits of physical activity may include improved
agility and coordination, as well as increased muscle strength that may lower the
likelihood of experiencing a fall, and therefore reducing fracture risk (2,29 ,30,32).
Estrogen use in former and cmTent female users was significantly associated with
decreased hip fracture risk . Estrogen deficiency due to menopause accelerates bone
loss (2,4,24,25). BMD losses of 2-4% occur up to five to ten years after menopause
in the absence of estrogen replacement therapy (2).
Smoking status and alcohol usage were significantly associated with hip fracture
risk in women but no such association was found in men. This may be due to the
small sample size of male participants. Some studies have reported lower BMD and
increased risk of fractures with cigarette smoking (2, 10). Excessive alcohol intake is
a strong risk factor for bone loss and fractures (2, 15). Increased risk of fractures may
also be due to loss of physical ability (2,10). Excessive alcohol intake may lead to
protein and/or calcium malnutrition, reduced mobility , and hypogonadism (5).
Chronic alcohol use increases fracture risk due to falls and hepatic disease (2).
Hepatic encephalopathy, resulting in decreased cognitive ability, may lead to
increased fall rates as a result of decreased functionality and cognition.
Table 7 demonstrates that in female participants, that along with increased BMI ,
there was a significant association between hip :fracture and type 2 diabetes. Two of
the primary risk factors for type 2 diabetes are obesity and sedentary living
(7,44,45,46,70). Greater than 8 out of 10 persons with type 2 diabetes are considered
overweight (46). The higher the proportion of fatty tissue in the body , the greater the
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resistance to insulin in muscle and tissue cells (46,5 8). It may be that proper
glucose control minimizes diabetic complications and is more correlated with body
weight and physical activity levels. In addition, persons with type 2 diabetes can
impro ve serum glucose levels by moderate weight loss (46). Therefore, increased
body weight and sedentary living may contribute to poor glycemic control , diabetic
complications and physical disability (2, 78). Physical disability, loss of
independence , and diminished quality of life may increase hip fracture risk (78).
Functional disability may lead to further complications of diabetes including
hyper glycemia , obesity, cardiovascular disease , peripheral vascular disease,
depre ssion, arthritis, and limited physical activity (78). It is possible that diabetic
complications have a direct impact on hip fractme risk. Osteoporosis associated with
diabetes is worse in people with poor glycemic control (3,63,7 9). Poor glycemic
control may result in hypercalciuria leading to negative calcium balance and
secondary hyperparath yroi dism. Consequently, bone resorption and bone loss may
ensue (79). Diabetic complications increase hip fracture risk either directly or
indirectl y. Poor glycemic control can also lead to hypoglycemic episodes resulting in
increased fall rates and increased hip fracture risk (2,27, 76). Poor glycemic control
also impacts visual acuity and can cause diabet ic retinopathy thereby increasing the
likelihood of falling (2, 10,63, 77).
Table 8 indicates that male participants with high BMis may have some
protection against hip fractures for type 2 diabetics however; caution should be taken
because statistical significance was not found. Adipose tissue surrounding the
femoral hip may provide a protective cushion in the event of a fall (2,21 ,22) .
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Moreover, it has been suggested that the most consistent predictor of BMD is total
body fat (22,23). Greater total body fat results in elevated BMD.
Of greater importance to future research is the fact that this study showed that
type 2 diabetes is a risk factor for hip fracture, supporting the hypothesis of this
research that type 2 diabetes increases risk for hip fracture. However , the casecontrol design of this study carmot be used to unequivocally state that type 2 diabetes
causes hip fracture. Rather , this study establishes that there is a strong association
between hip fracture risk and type 2 diabetes. Type 2 diabetes is multifactorial and
many underlying factors contribute to the development of type 2 diabetes. Many of
these factors could pose a risk for hip fracture.
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SUMMARY

Osteoporotic hip fractures severely affect quality of life by dimjnishing
functional capacity to perform routine activities (1,2,7). Critical prevention to delay ,
or eliminate susceptibility to hip fracture , must focus on high-risk populations and
administering proper treatment (7). The diabetic population may be at high-risk for
hip fractures due to the multifactorial nature of diabetes mellitus and osteoporosis
(3, 13). The focus ohms study was to perform a statistical analysis on various data
collected in the Utah Study of Nutrition and Bone Health (USNBH) to determine
whether there was an association between type 2 diabetes and mp fracture, wmch was
the case based upon the analysis of the data in tlus study. Therefore , the hypothesis
that type 2 diabetes is associated with increased risk of osteoporotic hip fracture is
acceptable. The results and conclusions derived from the data may eventually lead to
better therapy for treating and/or minimizing hip fracture incidence.
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